IVD regulation reform, antimicrobial resistance policies, CMS coverage and ;payment issues CMS coverage determination process, delay in PAMA implementation IVD regulatory reform, CMS coverage determination process IVD regulatory reform, point of care testing
HCR - Health Issues MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs SCI - Science/Technology
132 - Agency for Healthcare Research & Quality (AHRQ) 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 12 - White House Office 132 - Agency for Healthcare Research & Quality (AHRQ) 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 12 - White House Office 132 - Agency for Healthcare Research & Quality (AHRQ) 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 12 - White House Office 132 - Agency for Healthcare Research & Quality (AHRQ) 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 12 - White House Office
CEPHEID
2200 Pennsylvania Ave NW, Suite 800 W, Washington, DC, DC, 20037, US
MICHELE M SCHOONMAKER MICHELE M SCHOONMAKER MICHELE M SCHOONMAKER MICHELE M SCHOONMAKER